Pushing the Limits for the Surgical Treatment of Intrahepatic Cholangiocarcinoma
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Song L, Qingdong W, Shunhang Y, Long L, Guangsheng Z, Guangji Y World J Surg Oncol. 2025; 23(1):21.
PMID: 39856751 PMC: 11761194. DOI: 10.1186/s12957-025-03679-4.
References
1.
Sapisochin G, Ivanics T, Heimbach J
. Liver Transplantation for Intrahepatic Cholangiocarcinoma: Ready for Prime Time?. Hepatology. 2021; 75(2):455-472.
DOI: 10.1002/hep.32258.
View
2.
Buettner S, Cate D, Bagante F, Alexandrescu S, Marques H, Lamelas J
. Survival after Resection of Multiple Tumor Foci of Intrahepatic Cholangiocarcinoma. J Gastrointest Surg. 2019; 23(11):2239-2246.
PMC: 6831534.
DOI: 10.1007/s11605-019-04184-2.
View
3.
Wintachai P, Lim J, Techasen A, Lert-Itthiporn W, Kongpetch S, Loilome W
. Diagnostic and Prognostic Value of Circulating Cell-Free DNA for Cholangiocarcinoma. Diagnostics (Basel). 2021; 11(6).
PMC: 8228499.
DOI: 10.3390/diagnostics11060999.
View
4.
Rizzo A, Brandi G
. Neoadjuvant therapy for cholangiocarcinoma: A comprehensive literature review. Cancer Treat Res Commun. 2021; 27:100354.
DOI: 10.1016/j.ctarc.2021.100354.
View
5.
Sposito C, Ratti F, Cucchetti A, Ardito F, Ruzzenente A, Di Sandro S
. Survival benefit of adequate lymphadenectomy in patients undergoing liver resection for clinically node-negative intrahepatic cholangiocarcinoma. J Hepatol. 2022; 78(2):356-363.
DOI: 10.1016/j.jhep.2022.10.021.
View